Vol 11, No 4 (August 31, 2022): Chinese Clinical Oncology

Review Article

Immunometabolism, a new therapeutic development for immunotherapies of high-grade gliomas: a narrative review

Janet Y. Wu, Alexander L. Ren, Michael Lim

PDF Pages: 26 Full Text (2312) Reporting Checklist COI Form Open Access

The challenging surgical management of hepatic epithelioid hemangioendothelioma: a narrative review

Francesco Giovanardi, Zoe Larghi Laureiro, Gerardina Anna Meo, Redan Hassan, Quirino Lai

PDF Pages: 27 Full Text (1902) Reporting Checklist COI Form Open Access

Non-colorectal non-neuroendocrine liver metastasis: a narrative review of surgical treatment

Celeste Del Basso, Sofia Usai, Giovanni Battista Levi Sandri

PDF Pages: 28 Full Text (1921) Reporting Checklist COI Form Open Access

A narrative review on the management of glioblastoma in China

Ming-Juan Zhao, Taojunjing Lu, Chao Ma, Ze-Fen Wang, Zhi-Qiang Li

PDF Pages: 29 Full Text (3211) Reporting Checklist COI Form Open Access

Measuring response to neoadjuvant therapy using biomarkers in pancreatic cancer: a narrative review

Catherine Valukas, Akhil Chawla

PDF Pages: 30 Full Text (2398) Reporting Checklist Peer Review File COI Form Open Access

Original Article

Progression of citation-based scholarly activity from postgraduate year one to postgraduate year two in a current resident class

Shearwood McClelland III, Blair Murphy, Kristina D. Woodhouse, Richard C. Zellars

PDF Pages: 31 Full Text (1198) Reporting Checklist Data Sharing Statement COI Form Open Access

Interviews with Outstanding Guest Editors¹

Interview with Prof. Savio George Barreto: pancreatic cancer—an old problem needs a fresh perspective

Savio George Barreto, Yixuan Zeng, Lucine M. Gao

PDF Pages: 32 Full Text (1643) COI Form Open Access

Interview with Prof. Rimas V. Lukas: discussion with an academic neuro-oncologist

Rimas V. Lukas, Yixuan Zeng, Lucine M. Gao

PDF Pages: 33 Full Text (1826) COI Form Open Access

Disclosure:

1. The series “Interviews with Outstanding Guest Editors” was commissioned by the editorial office, Chinese Clinical Oncology without any funding or sponsorship.